US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
MedPage Today2d
COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...
Dog food pulled from shelves nationwide: FDA
The U.S. Food and Drug Administration reports a pet food company is voluntarily withdrawing some of their beef and chicken ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics
The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
US FDA lifts clinical hold on Biomea's diabetes trials after safety review
The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for ...
Bristol Myers wins US FDA approval for new type of schizophrenia drug
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
Scones Recall Update As FDA Sets Risk Level
Batches of Blueberry and Marionberry Scones have been recalled because of undeclared soy lecithin and soybean oil on the ...
FDA’s proposed packaged food labels won’t fix our obesity epidemic
A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...
Bristol-Myers Stock Gains on FDA Approval for New Schizophrenia Drug
Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...